Latest filingSep 16, 2026Most recent Form 4
PVLA
PALVELLA THERAPEUTICS, INC.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/16 to 09/16. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$482M14 sells
Net open-market-$482M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period18transactions
- S · Open-market sells · dominant14 · 78%
- M · Option exercise4 · 22%
Activity by reported role
A joint filing can contribute to multiple roles18transactions
- COO · dominant9 · 50%
- Director9 · 50%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeJenkins George MCommon Stock · Direct
160,676Sep 15, 2026
Goin KathleenCommon Stock · Direct
4,302Aug 19, 2026
Goin KathleenStock Option (Right to Buy) · Direct
4,319Aug 19, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 16 → Sep 16
LessMore
Top insiders
By absolute net value across the selected period- JM-$4.2M
- GK-$619.9k
Recent filing activity
Most recent 12 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
PVLA transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #220182 | PVLA | Jenkins George M | DIR | sale10b5-1 | 560 | -$8.47M | S | 09/16 | 09/15 |
| #220181 | PVLA | Jenkins George M | DIR | sale10b5-1 | 263 | -$3.95M | S | 09/16 | 09/15 |
| #220180 | PVLA | Jenkins George M | DIR | sale10b5-1 | 954 | -$14.2M | S | 09/16 | 09/15 |
| #220179 | PVLA | Jenkins George M | DIR | sale10b5-1 | 1.56k | -$23.8M | S | 09/16 | 09/14 |
| #220178 | PVLA | Jenkins George M | DIR | sale10b5-1 | 6.16k | -$93.7M | S | 09/16 | 09/14 |
| #220177 | PVLA | Jenkins George M | DIR | sale10b5-1 | 5.63k | -$85.3M | S | 09/16 | 09/14 |
| #220176 | PVLA | Jenkins George M | DIR | sale10b5-1 | 1.27k | -$19.4M | S | 09/16 | 09/11 |
| #220175 | PVLA | Jenkins George M | DIR | sale10b5-1 | 4.57k | -$69.4M | S | 09/16 | 09/11 |
| #220174 | PVLA | Jenkins George M | DIR | sale10b5-1 | 6.52k | -$98.2M | S | 09/16 | 09/11 |
| #12850 | PVLA | Goin Kathleen | COO | exercise10b5-1 | 2.14k | $0 | M | 08/20 | 08/19 |
| #12849 | PVLA | Goin Kathleen | COO | exercise10b5-1 | 2.15k | $0 | M | 08/20 | 08/19 |
| #12848 | PVLA | Goin Kathleen | COO | sale10b5-1 | 302 | -$4.73M | S | 08/20 | 08/19 |
| #12847 | PVLA | Goin Kathleen | COO | sale10b5-1 | 102 | -$1.58M | S | 08/20 | 08/19 |
| #12846 | PVLA | Goin Kathleen | COO | sale10b5-1 | 400 | -$6.11M | S | 08/20 | 08/19 |
| #12845 | PVLA | Goin Kathleen | COO | sale10b5-1 | 1.99k | -$30.3M | S | 08/20 | 08/19 |
| #12844 | PVLA | Goin Kathleen | COO | sale10b5-1 | 1.50k | -$22.7M | S | 08/20 | 08/19 |
| #12843 | PVLA | Goin Kathleen | COO | exercise10b5-1 | 2.14k | $1.95M | M | 08/20 | 08/19 |
| #12842 | PVLA | Goin Kathleen | COO | exercise10b5-1 | 2.15k | $1.53M | M | 08/20 | 08/19 |
PALVELLA THERAPEUTICS, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at PALVELLA THERAPEUTICS, INC.?
JENKINS GEORGE M, Goin Kathleen.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Jenkins George M reported a sale on Sep 15, 2026 valued at $8.47M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $4,821,936.99. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.